S&P 500
7,585.60
+0.04%
Dow Jones
52,712.50
-0.01%
Nasdaq 100
29,531.90
-0.08%
Russell 2000
2,979.64
-0.06%
FTSE 100
10,471.00
-0.16%
Nikkei 225
66,920.10
-1.14%

Investing

CMPX logo Compass Therapeutics : CMPX

CMPX

Stock Data

$2.14

Change down

$0.05 (2.28%)

Asset Type

N/A

Exchange

N/A

Currency

N/A

Country

N/A

Sector

N/A

Industry

N/A

Compass Therapeutics Inc is a biopharmaceutical company focused on creating innovative antibody therapies for cancer treatment. Based in Boston, Massachusetts, since 2014, it pioneers in developing drugs like CTX-009, CTX-471, and CTX-8371, targeting critical pathways and receptors involved in tumor growth and immune response. Their research aims to unlock new possibilities in oncology, offering hope for better, more effective treatments.

All Compass Therapeutics Articles

1 Article